These differences occurred in healthy rats due to some kidney problems that were more affected by the treatment with the CP solution (anemia), less affected after treatment with the γ-CD/CP binary complex, and almost not affected by using the antioxidant-protected γ-CD/Rv/CP ternary complex. The gene discussed is CP; the disease is anemia (phenotype).